HistoSonics Presents Preclinical Results at World Conference on Interventional Oncology (WCIO); Names MedTech Executives to Key Roles

ANN ARBOR, Mich. (June 7, 2017) — HistoSonics, Inc., a venture-backed medical device company developing a new image-guided, robotically assisted, platform therapy that is non-invasive and non-thermal, announced two significant developments today. Presentations at WCIO 2017 Researchers from the University … Read More